Imperagen raises £5 million to accelerate enzyme engineering with AI
Imperagen, a biotech startup from the UK just scored £5 million (about $6.7 million) in seed funding to make enzyme engineering faster and cheaper.
Founded in 2021 by scientists from Manchester Institute of Biotechnology, the company is using smart tech (think quantum physics simulations and AI) to predict how enzymes will behave, so they can skip a lot of old-school lab work.
Imperagen to expand research and hiring
The new cash will help them boost their research, grow their labs, hire more AI talent, and build a go-to-market function over the next two years.
Their tech isn't just for science geeks: it could change how things are made in pharma, biofuels, and even food.
Incoming CEO Guy Levy-Yurista says they're all about creating sustainable solutions that actually work in the real world.
With total funding now at £8.5 million (around $11.4 million), Imperagen is aiming to make industrial processes smarter everywhere.